 After a long-standing collaboration with Georgia, the EMCDDA launched its first bilateral technical cooperation project, EMCDDA for Georgia, in 2021. The project started from a needs assessment among Georgian stakeholders. One of the identified priorities was the development of a National Drugs Observatory, which provides the country with factual, objective, reliable, and comparable drug-related information. A National Drug Observatory was created in Georgia back in 2020. So when the project started in 2021, there was still a lot we had to learn. And as of today, there are many things that we've done with the project. And by stakeholders, we are recognized as the evidence-based drug policy coordination body and the observatory. Particular emphasis was put on getting more reliable data on drug use in the general population. The GPS study was important for us because it allows us to examine the trends in substance use. There was reduction in the amount of alcohol consumed. There was a reduction in rates of consumption of psychotropic medications. We also observed some increase in the use of cannabis. However, at this stage, it's challenging to say whether it was a real increase or it was an increase in reporting of cannabis used due to changed legislation. A second priority for the EMCDDA for Georgia project focused on reinforcing the Georgian prevention and treatment capacity. The European Prevention Curriculum is a European training curriculum on substance use prevention for decision, opinion and policy makers. In the framework of the EMCDDA for Georgia project, we translated and adapted it to the Georgian context. In the field of drug treatment, we developed and piloted a tailored training course for practitioners. The project is very responsive and sensitive to Georgian's needs. Because before the project started, a series of meetings with the local stakeholders took place. The mini-guides project was a response to the local needs. Needs to have some treatment guidelines and some orientation in contemporary new, relevant, evidence-based treatment approaches. And we also joined the UPC process. So the project showed the usefulness of a tailored approach in international cooperation, both at national and European level. In Georgia, the National Drug Observatory is much stronger and sustainable than before. And we have now more reliable data on drug-related key indicators. And at the same time, the project also allowed the EMCDDA to develop tools, such as the assessment of the National Drug Observatories and the training for drug treatment professionals, tools which will be used in the future also in other countries.